Phase 1 HER2-positive Advanced Solid Tumor Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
HER2-positive Advanced Solid Tumor
DualityBio Inc.796 enrolled102 locationsNCT05150691
Recruiting
Phase 1Phase 2
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
HER2-Positive Advanced Solid Tumors
Chinese PLA General Hospital30 enrolled1 locationNCT05681650
Recruiting
Phase 1
Phase I Dose Finding Study in Patients with HER2-Positive Advanced Solid Tumors
HER2-Positive Advanced Solid Tumors
Conjugate Light (Australia) Pty Ltd13 enrolled1 locationACTRN12620000592943